|
|
|
|
|
PEER-TO-PEER CLINICAL CONVERSATIONS |
|
|
|
|
|
|
Biological Difference Based on Race: Disparities Throughout the Spectrum of Prostate Cancer
|
Kosj Yamoah, MD, Ph.D.
In this conversation, Charles Ryan and Kosj Yamoah discuss the importance of attention to disparities in prostate cancer care delivery. They reflect back on how far the field has come in this space highlighting Kosj Yamoah's Young Investigator Award research which hypothesized a biological difference based on race will lead to disparities throughout the spectrum of the disease.
|
|
|
|
|
|
|
|
|
|
|
| Disparities in Prostate Cancer: Barriers to Access to Clinical Trials |
Elisabeth Heath, MD, FACP
Alicia Morgans is joined by Elisabeth Heath of the Karmanos Cancer Institute in a discussion on disparities in prostate cancer focusing on the barriers in enrolling African American men with prostate cancer in clinical trials. |
|
|
|
|
|
|
|
|
|
|
| Radiotherapy Deserts in Prostate Cancer: Radiation Resource Density & Use in the US |
Sara Alcorn, MD, MPH, Ph.D. and Anna LaVigne, MD
PCF-Pfizer Health Equity Challenge Award recipients Sara Alcorn and Anna LaVigne join Charles Ryan in a discussion on the awareness and understanding of existing oncologic disparities in the diagnosis, treatment, and outcomes of prostate cancer patients. |
|
|
|
|
|
|
|
|
|
|
|
Genomic Analysis and Assessment of Treatment Patterns To Better Understand Disparities in Advanced Prostate Cancer
|
|
Brandon Mahal, MD
|
| In this UroToday discussion, Charles Ryan and Brandon Mahal discuss Dr. Mahal’s update to his study that was published in last year’s New England Journal of Medicine, looking at the differences in mutational landscape, of advanced prostate cancer patients, between men with European and African ancestry.
|
|
|
|
|
|
|
|
|
|
|
|
| Are We Making Progress in Addressing Disparities in Prostate Cancer?
|
| Peter C. Black, MD
|
| Peter Black reviews three abstracts focused on addressing the increased incidence and mortality in African American men (AAM) with prostate cancer. He framed his discussion around the fact that prostate cancer outcomes could be equivalent by race if all patients received a timely diagnosis, had adequate staging and risk stratification, and received equitable and correct treatment delivery. He ends his discussion by asking whether the field is making progress in addressing disparities in prostate cancer. Dr. Black suggests that we are identifying and documenting disparities through research, and these disparities are receiving national attention.
|
|
|
|
|
|
| Disparities in Delayed Diagnosis, Access to Treatment, and Treatment Delays Among Hispanic Men With Metastatic Prostate Cancer
|
| Nishwant Swami, MPH
|
| Nishwant Swami describes disparities in diagnosis, access to treatment, and treatment delays for Hispanic men with metastatic prostate cancer. The authors demonstrate notable disparities in prostate cancer diagnosis and treatment for Hispanic men, with meaningful differences when stratified by racial subgroup and Hispanic country of origin.
|
|
|
|
|
|
|
|
|
|
|
| Addressing Racial Disparities in Urologic Cancer |
| Randy A. Vince Jr., MD |
| In a podium presentation at the 2022 Society of Urologic Oncology Meeting held in conjunction with the American Urologic Association Annual Meeting held in New Orleans and virtually, Dr. Randy Vince discussed the interaction of race, social determinants of health, and cancer outcomes. |
|
|
|
|
|
| A Path Forward: Addressing Disparities in Genitourinary Cancers |
| Karen E. Knudsen, Ph.D., MBA |
| Karen Knudsen, Chief Executive Officer of the American Cancer Society (ACS), presents a keynote lecture focusing on the path forward to address disparities in genitourinary cancers. Dr. Knudsen emphasized the importance of genitourinary cancer in the overall burden of cancer in the United States, as well as numerous concerning disparities and trends across each of the urologic malignancies. |
|
|
|
|
|
| Racial Concordance and Trust in Health Communications: A Randomized Trial of Videos About Prostate Cancer |
| Stacy Loeb, MD |
| Stacy Loeb presents a randomized trial of 2904 U.S. adults age ≥ 40 that sought to evaluate the association between racial representation in online content about prostate cancer and trust in the content. A secondary objective was to identify additional attributes that influence trust in online content. The authors conclude that while there is no difference among White adults, there is a significant association between racial concordance of the presenter and trust in prostate cancer information among Black adults. |
|
|
|
|
|
|
